TY - JOUR
T1 - Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential
AU - Khan, S.
AU - Aspe, J. R.
AU - Asumen, M. G.
AU - Almaguel, F.
AU - Odumosu, O.
AU - Acevedo-Martinez, S.
AU - De Leon, M.
AU - Langridge, W. H.R.
AU - Wall, N. R.
N1 - Funding Information:
This study was supported by NCMHD Project EXPORT Program 5P20MD001632/Project 3 (NR Wall). This work was also funded as part of a start-up package by Loma Linda University’s Center for Molecular Biology and Gene Therapy, now the Center for Health Disparities Research and Molecular Medicine (NRW), and by the Hirschberg Pancreatic Cancer Foundation (NRW). We thank Drs Viven Mao and Laura Green for help with the confocal microscopy, Dalmor McGregor for making the survivin recombinant protein, and Nic Galloway and Jessica Slater for reviewing this article.
PY - 2009/4/7
Y1 - 2009/4/7
N2 - The tumour microenvironment is believed to be involved in development, growth, metastasis, and therapy resistance of many cancers. Here we show survivin, a member of the inhibitor of apoptosis protein (IAP) family, implicated in apoptosis inhibition and the regulation of mitosis in cancer cells, exists in a novel extracellular pool in tumour cells. Furthermore, we have constructed stable cell lines that provide the extracellular pool with either wild-type survivin (Surv-WT) or the previously described dominant-negative mutant survivin (Surv-T34A), which has proven pro-apoptotic effects in cancer cells but not in normal proliferating cells. Cancer cells grown in conditioned medium (CM) taken from Surv-WT cells absorbed survivin and experienced enhanced protection against genotoxic stresses. These cells also exhibited an increased replicative and metastatic potential, suggesting that survivin in the tumour microenvironment may be directly associated with malignant progression, further supporting survivin's function in tumourigenesis. Alternatively, cancer cells grown in CM taken from the Surv-T34A cells began to apoptose through a caspase-2- and caspase-9-dependent pathway that was further enhanced by the addition of other chemo- and radiotherapeutic modalities. Together our findings suggest a novel microenvironmental function for survivin in the control of cancer aggressiveness and spread, and should result in the genesis of additional cancer treatment modalities. © 2009 Cancer Research UK. All rights reserved.
AB - The tumour microenvironment is believed to be involved in development, growth, metastasis, and therapy resistance of many cancers. Here we show survivin, a member of the inhibitor of apoptosis protein (IAP) family, implicated in apoptosis inhibition and the regulation of mitosis in cancer cells, exists in a novel extracellular pool in tumour cells. Furthermore, we have constructed stable cell lines that provide the extracellular pool with either wild-type survivin (Surv-WT) or the previously described dominant-negative mutant survivin (Surv-T34A), which has proven pro-apoptotic effects in cancer cells but not in normal proliferating cells. Cancer cells grown in conditioned medium (CM) taken from Surv-WT cells absorbed survivin and experienced enhanced protection against genotoxic stresses. These cells also exhibited an increased replicative and metastatic potential, suggesting that survivin in the tumour microenvironment may be directly associated with malignant progression, further supporting survivin's function in tumourigenesis. Alternatively, cancer cells grown in CM taken from the Surv-T34A cells began to apoptose through a caspase-2- and caspase-9-dependent pathway that was further enhanced by the addition of other chemo- and radiotherapeutic modalities. Together our findings suggest a novel microenvironmental function for survivin in the control of cancer aggressiveness and spread, and should result in the genesis of additional cancer treatment modalities. © 2009 Cancer Research UK. All rights reserved.
KW - Apoptosis
KW - Metastasis
KW - Surviving
KW - Tumour microenvironment
KW - Neoplasms/pathology
KW - Cell Proliferation
KW - Inhibitor of Apoptosis Proteins
KW - Neoplasm Invasiveness
KW - Humans
KW - Microtubule-Associated Proteins/analysis
KW - Survivin
KW - Neoplasm Metastasis
KW - Cell Cycle
KW - Membrane Potential, Mitochondrial
KW - Cell Line, Tumor
UR - http://www.scopus.com/inward/record.url?scp=63949085987&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=63949085987&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/f209cd24-1eda-34b5-a149-a8ae53d9922a/
U2 - 10.1038/sj.bjc.6604978
DO - 10.1038/sj.bjc.6604978
M3 - Article
C2 - 19293795
SN - 0007-0920
VL - 100
SP - 1073
EP - 1086
JO - British Journal of Cancer
JF - British Journal of Cancer
IS - 7
ER -